Johannes Woitzik

Johannes Woitzik

Auto-generated profile, based on publicly available information

Johannes Woitzik

Department of Neurosurgery, Carl von Ossietzky University Oldenburg, Oldenburg, Germany

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 April 2014 in Journal of Cerebral Blood Flow & Metabolism
Verified
Journal Article
Open access
NHNils Hecht
Nils Hecht
USUlf C Schneider
Ulf C Schneider
MCMarcus Czabanka
Marcus Czabanka
Maria VinciMaria Vinci
Maria Vinci
AHAntonis K Hatzopoulos
Antonis K Hatzopoulos
JWJohannes Woitzik
Johannes Woitzik
Surgical flow augmentation for treatment of cerebral hemodynamic impairment remains controversial. Here, we investigated the benefit of endothelial progenitor cell (EPC) treatment in a rat model of chronic cerebral hypoperfusion. At repeated time points after 3-vessel occlusion (3-VO), animals were treated with 1 × 10 6 Dil-labeled (a) ex vivo-expanded embryonic-EPC (e-EPC), (b) cyclic AMP-differentiated embryonic-endothelial progenitor-derived cells (e-EPDC as biologic control) or, (c) saline. The cerebrovascular reserve capacity (CVRC) was assessed immediately before and on days 7 and 21 after 3-VO. Structural effects were assessed by latex perfusion, immunohistochemistry, and intravital fluorescence video microscopy on day 21. Three-vessel occlusion resulted in a significant impairment of the CVRC with better functional recovery after treatment with e-EPC (16.4 ± 8%) compared with e-EPDC (3.7 ± 8%) or saline (6.4 ± 9%) by day 21 ( P<0.05), which was paralleled by a significant increase in the vessel diameters of the anterior Circle of Willis, a significantly higher number of leptomeningeal anastomoses and higher parenchymal capillary density in e-EPC-treated animals. Interestingly, despite in vivo interaction of e-EPC with the cerebral endothelium, e-EPC incorporation into the cerebral vasculature was not observed. Our results suggest that EPC may serve as a novel therapeutic agent in clinical trials for nonsurgical treatment of chronic cerebral hemodynamic impairment.

3 June 2009 in Journal of Cerebral Blood Flow & Metabolism
Verified
Journal Article
Open access
MCMarcus Czabanka
Marcus Czabanka
PPPablo Peña-Tapia
Pablo Peña-Tapia
GSGerrit Alexander Schubert
Gerrit Alexander Schubert
JWJohannes Woitzik
Johannes Woitzik
PHPeter Horn
Peter Horn
Peter VajkoczyPeter Vajkoczy
Peter Vajkoczy
We analyzed cortical microvascular parameters using intraoperative ICG (Indocyaninegreen)-Videoangiography in 13 patients with Moyamoya disease, and carried out correlative studies by comparing them with clinical parameters obtained by digital subtraction angiography, physical examination, and regional cerebral blood flow studies. Patients with reduced cerebrovascular reserve capacity were characterized by increased microvascular surface area (MVSA). In addition, MVSA correlated positively with arterial microvascular transit time. Asymptomatic patients were characterized by increased arterial microvascular transit time. We show that patients with a higher arteriogenic potential to alter cortical microvasculature are characterized by a more favorable hemodynamic situation and reduced clinical symptoms.

25 April 2016 in Clinical Neuroradiology
Verified
Journal Article
Closed access
PDF file
JBJulia S. Bretz
Julia S. Bretz
FDFalk Von Dincklage
Falk Von Dincklage
JWJohannes Woitzik
Johannes Woitzik
MWMaren K. L. Winkler
Maren K. L. Winkler
SMSebastian Major
Sebastian Major
MSMichael Scheel
Michael Scheel

24 August 2021 in Journal of Cerebral Blood Flow & Metabolism
Verified
Journal Article
Closed access
PDF file
LSLeonie Schumm
Leonie Schumm
CLColine L Lemale
Coline L Lemale
SMSebastian Major
Sebastian Major
NHNils Hecht
Nils Hecht
MNMelina Nieminen-Kelhä
Melina Nieminen-Kelhä
JWJohannes Woitzik
Johannes Woitzik
Physiological effects of spreading depolarizations (SD) are only well studied in the first hours after experimental stroke. In patients with malignant hemispheric stroke (MHS), monitoring of SDs is restricted to the postoperative ICU stay, typically day 2-7 post-ictus. Therefore, we investigated the role of physiological variables (temperature, intracranial pressure, mean arterial pressure and cerebral perfusion pressure) in relationship to SD during the late phase after MHS in humans. Additionally, an experimental stroke model was used to investigate hemodynamic consequences of SD during this time window. In 60 patients with MHS, the occurrence of 1692 SDs was preceded by a decrease in mean arterial pressure (−1.04 mmHg; p = .02) and cerebral perfusion pressure (−1.04 mmHg; p = .03). Twenty-four hours after middle cerebral artery occlusion in 50 C57Bl6/J mice, hypothermia led to prolonged SD-induced hyperperfusion (+2.8 min; p < .05) whereas hypertension mitigated initial hypoperfusion (−1.4 min and +18.5%Δ rCBF; p < .01). MRI revealed that SDs elicited 24 hours after experimental stroke were associated with lesion progression (15.9 vs. 14.8 mm³; p < .01). These findings of small but significant effects of physiological variables on SDs in the late phase after ischemia support the hypothesis that the impact of SDs may be modified by adjusting physiological variables.

14 June 2022 in Operative Neurosurgery
Verified
Journal Article
Closed access
FMFranziska Meinert
Franziska Meinert
PDPatrick Dömer
Patrick Dömer
SHSimeon Oscar Arnulfo Helgers
Simeon Oscar Arnulfo Helgers
LSLeonie Schumm
Leonie Schumm
NHNils Hecht
Nils Hecht
JWJohannes Woitzik
Johannes Woitzik

3 May 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
AZA. Zdunczyk
A. Zdunczyk
LSL. Schumm
L. Schumm
SHS. O. A. Helgers
S. O. A. Helgers
MNM. Nieminen-Kelhä
M. Nieminen-Kelhä
XBX. Bai
X. Bai
JWJohannes Woitzik
Johannes Woitzik
Spreading depolarizations (SDs) occur frequently in patients with malignant hemispheric stroke. In animal-based experiments, SDs have been shown to cause secondary neuronal damage and infarct expansion during the initial period of infarct progression. In contrast, the influence of SDs during the delayed period is not well characterized yet. Here, we analyzed the impact of SDs in the delayed phase after cerebral ischemia and the potential protective effect of ketamine. Focal ischemia was induced by distal occlusion of the left middle cerebral artery in C57BL6/J mice. 24 h after occlusion, SDs were measured using electrocorticography and laser-speckle imaging in three different study groups: control group without SD induction, SD induction with potassium chloride, and SD induction with potassium chloride and ketamine administration. Infarct progression was evaluated by sequential MRI scans. 24 h after occlusion, we observed spontaneous SDs with a rate of 0.33 SDs/hour which increased during potassium chloride application (3.37 SDs/hour). The analysis of the neurovascular coupling revealed prolonged hypoemic and hyperemic responses in this group. Stroke volume increased even 24 h after stroke onset in the SD-group. Ketamine treatment caused a lesser pronounced hypoemic response and prevented infarct growth in the delayed phase after experimental ischemia. Induction of SDs with potassium chloride was significantly associated with stroke progression even 24 h after stroke onset. Therefore, SD might be a significant contributor to delayed stroke progression. Ketamine might be a possible drug to prevent SD-induced delayed stroke progression.